Creative Medical Technology Holdings (CELZ) Earnings Analysis

Creative Medical Technology Holdings (CELZ) next reports earnings on 2026-08-14, consensus EPS -0.39 USD. Last quarter (2026-05-08) it beat with EPS -0.38 USD vs -0.39 USD est (+2.6%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -0.41.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CELZ next report earnings?

Next earnings date2026-08-14
Consensus EPS estimate-0.39 USD
Revenue estimaten/a

CELZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.38 USD-0.39 USD+2.6%Beat
2026-03-20-0.8 USD-0.37 USD-116.2%Miss
2025-11-07-0.48 USD-0.48 USD0%Beat
2025-08-08-0.48 USD-0.63 USD+23.8%Beat
2025-05-09-0.83 USD-0.52 USD-59.6%Miss
2025-03-14-1.12 USD-0.63 USD-77.8%Miss
2024-11-08-0.75 USD-0.85 USD+11.8%Beat
2024-08-09-1.11 USD-0.84 USD-32.1%Miss

Beat rate: 4/8 (50%) over reported quarters with consensus data.

CELZ valuation and analyst view

Trailing P/E-0.41
Trailing EPS-1.55659 USD
Price / book0.51
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Creative Medical Technology Holdings (CELZ)'s next earnings date?

Creative Medical Technology Holdings is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.39 USD.

Did CELZ beat earnings last quarter?

In its 2026-05-08 report, CELZ posted EPS of -0.38 USD versus a -0.39 USD estimate — a beat of 2.6%.

What is CELZ's earnings track record?

Over the last 8 reported quarters with consensus data, CELZ beat estimates 4 times (50%).

What is CELZ's current P/E ratio and EPS?

CELZ trades at a trailing P/E of -0.41 on trailing EPS of -1.556592325405736 USD.

What do analysts rate CELZ?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).